메뉴 건너뛰기




Volumn 123, Issue 3, 2015, Pages 449-457

Glioblastoma stem cells and stem cell-targeting immunotherapies

Author keywords

Cancer stem cell; Glioblastoma; Immunotherapy

Indexed keywords

AMG 595; ANTINEOPLASTIC AGENT; BASILIXIMAB; BEVACIZUMAB; BORTEZOMIB; BUPARLISIB; CARBOPLATIN; CETUXIMAB; CHIMERIC ANTIGEN RECEPTOR; CYCLOPHOSPHAMIDE; DENDRITIC CELL VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DURVALUMAB; ERC 1671; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ICT 121; IMMUNOMODULATING AGENT; IPILIMUMAB; LOMUSTINE; MONOCLONAL ANTIBODY; NIVOLUMAB; PIDILIZUMAB; PLERIXAFOR; RESIQUIMOD; RINDOPEPIMUT; SAPANISERTIB; TEMOZOLOMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITESPEN; VORINOSTAT;

EID: 84937513374     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-015-1729-x     Document Type: Review
Times cited : (28)

References (60)
  • 1
    • 33745726808 scopus 로고    scopus 로고
    • Brain tumour stem cells
    • COI: 1:CAS:528:DC%2BD28XkvVylt78%3D, PID: 16723989
    • Vescovi AL, Galli R, Reynolds BA (2006) Brain tumour stem cells. Nat Rev Cancer 6:425–436. doi:10.1038/nrc1889
    • (2006) Nat Rev Cancer , vol.6 , pp. 425-436
    • Vescovi, A.L.1    Galli, R.2    Reynolds, B.A.3
  • 2
    • 84920999004 scopus 로고    scopus 로고
    • Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors
    • Chester C, Marabelle A, Houot R, Kohrt HE (2015) Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors. Curr Opin Immunol 33C:1–8. doi:10.1016/j.coi.2014.12.010
    • (2015) Curr Opin Immunol , vol.33C
    • Chester, C.1    Marabelle, A.2    Houot, R.3    Kohrt, H.E.4
  • 3
    • 0036737914 scopus 로고    scopus 로고
    • Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro
    • PID: 12203386
    • Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA (2002) Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39:193–206. doi:10.1002/glia.10094
    • (2002) Glia , vol.39 , pp. 193-206
    • Ignatova, T.N.1    Kukekov, V.G.2    Laywell, E.D.3    Suslov, O.N.4    Vrionis, F.D.5    Steindler, D.A.6
  • 4
    • 80053647284 scopus 로고    scopus 로고
    • Chemoresistance of glioblastoma cancer stem cells–much more complex than expected
    • COI: 1:CAS:528:DC%2BC3MXhs1Oht7nF, PID: 21988793
    • Beier D, Schulz JB, Beier CP (2011) Chemoresistance of glioblastoma cancer stem cells–much more complex than expected. Mol Cancer 10:128. doi:10.1186/1476-4598-10-128
    • (2011) Mol Cancer , vol.10 , pp. 128
    • Beier, D.1    Schulz, J.B.2    Beier, C.P.3
  • 5
    • 23644443053 scopus 로고    scopus 로고
    • Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma
    • COI: 1:CAS:528:DC%2BD2MXps1Ojt7s%3D, PID: 16098465
    • Zhu Y, Guignard F, Zhao D, Liu L, Burns DK, Mason RP, Messing A, Parada LF (2005) Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell 8:119–130. doi:10.1016/j.ccr.2005.07.004
    • (2005) Cancer Cell , vol.8 , pp. 119-130
    • Zhu, Y.1    Guignard, F.2    Zhao, D.3    Liu, L.4    Burns, D.K.5    Mason, R.P.6    Messing, A.7    Parada, L.F.8
  • 6
    • 38449087465 scopus 로고    scopus 로고
    • Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype
    • PID: 17622647
    • Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS (2007) Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro-oncol 9:424–429. doi:10.1215/15228517-2007-023
    • (2007) Neuro-oncol , vol.9 , pp. 424-429
    • Lim, D.A.1    Cha, S.2    Mayo, M.C.3    Chen, M.H.4    Keles, E.5    VandenBerg, S.6    Berger, M.S.7
  • 8
    • 84926076998 scopus 로고    scopus 로고
    • Stem cell signature in glioblastoma: therapeutic development for a moving target
    • PID: 25397368
    • Nakano I (2014) Stem cell signature in glioblastoma: therapeutic development for a moving target. J Neurosurg. doi:10.3171/2014.9.JNS132253
    • (2014) J Neurosurg
    • Nakano, I.1
  • 11
    • 59849125142 scopus 로고    scopus 로고
    • SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity
    • COI: 1:CAS:528:DC%2BD1MXisVeqsbo%3D, PID: 18948646
    • Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, Malatesta P, Ravetti GL, Zona GL, Daga A, Corte G (2009) SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 27:40–48. doi:10.1634/stemcells.2008-0493
    • (2009) Stem Cells , vol.27 , pp. 40-48
    • Gangemi, R.M.1    Griffero, F.2    Marubbi, D.3    Perera, M.4    Capra, M.C.5    Malatesta, P.6    Ravetti, G.L.7    Zona, G.L.8    Daga, A.9    Corte, G.10
  • 12
    • 51049101689 scopus 로고    scopus 로고
    • Targeting cancer stem cells through L1CAM suppresses glioma growth
    • COI: 1:CAS:528:DC%2BD1cXpt1Sqt7w%3D, PID: 18676824
    • Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN (2008) Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 68:6043–6048. doi:10.1158/0008-5472.CAN-08-1079
    • (2008) Cancer Res , vol.68 , pp. 6043-6048
    • Bao, S.1    Wu, Q.2    Li, Z.3    Sathornsumetee, S.4    Wang, H.5    McLendon, R.E.6    Hjelmeland, A.B.7    Rich, J.N.8
  • 16
    • 74549196076 scopus 로고    scopus 로고
    • HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors
    • COI: 1:CAS:528:DC%2BC3cXktF2qtr8%3D, PID: 20068073
    • Ahmed N, Salsman VS, Kew Y, Shaffer D, Powell S, Zhang YJ, Grossman RG, Heslop HE, Gottschalk S (2010) HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors. Clin Cancer Res 16:474–485. doi:10.1158/1078-0432.CCR-09-1322
    • (2010) Clin Cancer Res , vol.16 , pp. 474-485
    • Ahmed, N.1    Salsman, V.S.2    Kew, Y.3    Shaffer, D.4    Powell, S.5    Zhang, Y.J.6    Grossman, R.G.7    Heslop, H.E.8    Gottschalk, S.9
  • 17
    • 84859820456 scopus 로고    scopus 로고
    • Stem-like tumor-initiating cells isolated from IL13Ralpha2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells
    • COI: 1:CAS:528:DC%2BC38XmsFOntLw%3D, PID: 22407828
    • Brown CE, Starr R, Aguilar B, Shami AF, Martinez C, D’Apuzzo M, Barish ME, Forman SJ, Jensen MC (2012) Stem-like tumor-initiating cells isolated from IL13Ralpha2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells. Clin Cancer Res 18:2199–2209. doi:10.1158/1078-0432.CCR-11-1669
    • (2012) Clin Cancer Res , vol.18 , pp. 2199-2209
    • Brown, C.E.1    Starr, R.2    Aguilar, B.3    Shami, A.F.4    Martinez, C.5    D’Apuzzo, M.6    Barish, M.E.7    Forman, S.J.8    Jensen, M.C.9
  • 18
    • 0025981021 scopus 로고
    • T-lymphocyte entry into the central nervous system
    • COI: 1:STN:280:DyaK3M3jslOnug%3D%3D, PID: 2033653
    • Hickey WF, Hsu BL, Kimura H (1991) T-lymphocyte entry into the central nervous system. J Neurosci Res 28:254–260. doi:10.1002/jnr.490280213
    • (1991) J Neurosci Res , vol.28 , pp. 254-260
    • Hickey, W.F.1    Hsu, B.L.2    Kimura, H.3
  • 19
    • 77951837763 scopus 로고    scopus 로고
    • Trafficking of immune cells in the central nervous system
    • COI: 1:CAS:528:DC%2BC3cXlslSitrg%3D, PID: 20440079
    • Wilson EH, Weninger W, Hunter CA (2010) Trafficking of immune cells in the central nervous system. J Clin Invest 120:1368–1379. doi:10.1172/JCI41911
    • (2010) J Clin Invest , vol.120 , pp. 1368-1379
    • Wilson, E.H.1    Weninger, W.2    Hunter, C.A.3
  • 20
    • 61449224570 scopus 로고    scopus 로고
    • Microglia: gatekeepers of central nervous system immunology
    • COI: 1:CAS:528:DC%2BD1MXivVarsbw%3D, PID: 19028958
    • Tambuyzer BR, Ponsaerts P, Nouwen EJ (2009) Microglia: gatekeepers of central nervous system immunology. J Leukoc Biol 85:352–370. doi:10.1189/jlb.0608385
    • (2009) J Leukoc Biol , vol.85 , pp. 352-370
    • Tambuyzer, B.R.1    Ponsaerts, P.2    Nouwen, E.J.3
  • 23
    • 0036316548 scopus 로고    scopus 로고
    • Blood-brain barrier breakdown in septic encephalopathy and brain tumours
    • COI: 1:STN:280:DC%2BD38vgvVKjsQ%3D%3D, PID: 12162731
    • Davies DC (2002) Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 200:639–646
    • (2002) J Anat , vol.200 , pp. 639-646
    • Davies, D.C.1
  • 24
    • 84855604775 scopus 로고    scopus 로고
    • Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment
    • PID: 22190972
    • Jackson C, Ruzevick J, Phallen J, Belcaid Z, Lim M (2011) Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment. Clin dev Immunol 2011:732413. doi:10.1155/2011/732413
    • (2011) Clin dev Immunol , vol.2011 , pp. 732413
    • Jackson, C.1    Ruzevick, J.2    Phallen, J.3    Belcaid, Z.4    Lim, M.5
  • 26
    • 33645502885 scopus 로고    scopus 로고
    • Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma
    • COI: 1:CAS:528:DC%2BD28XitlertLs%3D, PID: 16540683
    • Fecci PE, Mitchell DA, Whitesides JF, Xie W, Friedman AH, Archer GE, Herndon JE 2nd, Bigner DD, Dranoff G, Sampson JH (2006) Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. Cancer Res 66:3294–3302. doi:10.1158/0008-5472.CAN-05-3773
    • (2006) Cancer Res , vol.66 , pp. 3294-3302
    • Fecci, P.E.1    Mitchell, D.A.2    Whitesides, J.F.3    Xie, W.4    Friedman, A.H.5    Archer, G.E.6    Herndon, J.E.7    Bigner, D.D.8    Dranoff, G.9    Sampson, J.H.10
  • 27
    • 28544444135 scopus 로고    scopus 로고
    • Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors
    • COI: 1:CAS:528:DC%2BD2MXht1KjsrjL, PID: 16322289
    • Facoetti A, Nano R, Zelini P, Morbini P, Benericetti E, Ceroni M, Campoli M, Ferrone S (2005) Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors. Clin Cancer Res 11:8304–8311. doi:10.1158/1078-0432.CCR-04-2588
    • (2005) Clin Cancer Res , vol.11 , pp. 8304-8311
    • Facoetti, A.1    Nano, R.2    Zelini, P.3    Morbini, P.4    Benericetti, E.5    Ceroni, M.6    Campoli, M.7    Ferrone, S.8
  • 28
    • 0028888764 scopus 로고
    • Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas
    • COI: 1:CAS:528:DyaK2MXkslahsbc%3D, PID: 7856743
    • Huettner C, Paulus W, Roggendorf W (1995) Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am J Pathol 146:317–322
    • (1995) Am J Pathol , vol.146 , pp. 317-322
    • Huettner, C.1    Paulus, W.2    Roggendorf, W.3
  • 29
    • 0025196599 scopus 로고
    • In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes
    • COI: 1:STN:280:DyaK3M%2Fos12ktw%3D%3D, PID: 2175768
    • Sawamura Y, Diserens AC, de Tribolet N (1990) In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes. J Neurooncol 9:125–130
    • (1990) J Neurooncol , vol.9 , pp. 125-130
    • Sawamura, Y.1    Diserens, A.C.2    de Tribolet, N.3
  • 30
    • 34248529706 scopus 로고    scopus 로고
    • Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1
    • COI: 1:CAS:528:DC%2BD2sXkt1Kjur0%3D, PID: 17440061
    • Roth P, Mittelbronn M, Wick W, Meyermann R, Tatagiba M, Weller M (2007) Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1. Cancer Res 67:3540–3544. doi:10.1158/0008-5472.CAN-06-4783
    • (2007) Cancer Res , vol.67 , pp. 3540-3544
    • Roth, P.1    Mittelbronn, M.2    Wick, W.3    Meyermann, R.4    Tatagiba, M.5    Weller, M.6
  • 32
    • 78049270536 scopus 로고    scopus 로고
    • Glioma cancer stem cells induce immunosuppressive macrophages/microglia
    • COI: 1:CAS:528:DC%2BC3cXhtlClu7fO, PID: 20667896
    • Wu A, Wei J, Kong LY, Wang Y, Priebe W, Qiao W, Sawaya R, Heimberger AB (2010) Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro-oncol 12:1113–1125. doi:10.1093/neuonc/noq082
    • (2010) Neuro-oncol , vol.12 , pp. 1113-1125
    • Wu, A.1    Wei, J.2    Kong, L.Y.3    Wang, Y.4    Priebe, W.5    Qiao, W.6    Sawaya, R.7    Heimberger, A.B.8
  • 33
    • 50249144131 scopus 로고    scopus 로고
    • Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
    • COI: 1:CAS:528:DC%2BD1cXhtFSrtbbJ, PID: 18553315
    • Komohara Y, Ohnishi K, Kuratsu J, Takeya M (2008) Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 216:15–24. doi:10.1002/path.2370
    • (2008) J Pathol , vol.216 , pp. 15-24
    • Komohara, Y.1    Ohnishi, K.2    Kuratsu, J.3    Takeya, M.4
  • 34
    • 84858785688 scopus 로고    scopus 로고
    • Antibody therapy of cancer
    • COI: 1:CAS:528:DC%2BC38XksVegsbs%3D, PID: 22437872
    • Scott AM, Wolchok JD, Old LJ (2012) Antibody therapy of cancer. Nat Rev Cancer 12:278–287. doi:10.1038/nrc3236
    • (2012) Nat Rev Cancer , vol.12 , pp. 278-287
    • Scott, A.M.1    Wolchok, J.D.2    Old, L.J.3
  • 35
    • 0030576517 scopus 로고    scopus 로고
    • Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
    • COI: 1:CAS:528:DyaK28XltVSks7s%3D, PID: 8756718
    • Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364
    • (1996) Cell , vol.86 , pp. 353-364
    • Hanahan, D.1    Folkman, J.2
  • 42
    • 0029899783 scopus 로고    scopus 로고
    • CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells
    • COI: 1:CAS:528:DyaK28XjslaisL0%3D, PID: 8676074
    • Krummel MF, Allison JP (1996) CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183:2533–2540
    • (1996) J Exp Med , vol.183 , pp. 2533-2540
    • Krummel, M.F.1    Allison, J.P.2
  • 43
    • 0029947568 scopus 로고    scopus 로고
    • Enhancement of antitumor immunity by CTLA-4 blockade
    • COI: 1:CAS:528:DyaK28XhvVWmsLk%3D, PID: 8596936
    • Leach DR, Krummel MF, Allison JP (1996) Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734–1736
    • (1996) Science , vol.271 , pp. 1734-1736
    • Leach, D.R.1    Krummel, M.F.2    Allison, J.P.3
  • 44
    • 84859258334 scopus 로고    scopus 로고
    • Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients
    • COI: 1:CAS:528:DC%2BC38XlsFykurk%3D, PID: 22485134
    • Fong B, Jin R, Wang X, Safaee M, Lisiero DN, Yang I, Li G, Liau LM, Prins RM (2012) Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients. PLoS ONE 7:e32614. doi:10.1371/journal.pone.0032614
    • (2012) PLoS ONE , vol.7 , pp. 32614
    • Fong, B.1    Jin, R.2    Wang, X.3    Safaee, M.4    Lisiero, D.N.5    Yang, I.6    Li, G.7    Liau, L.M.8    Prins, R.M.9
  • 47
    • 84881478223 scopus 로고    scopus 로고
    • What is the clinical value of cancer stem cell markers in gliomas?
    • COI: 1:CAS:528:DC%2BC3sXjvFKjtLk%3D, PID: 23412423
    • Dahlrot RH, Hermansen SK, Hansen S, Kristensen BW (2013) What is the clinical value of cancer stem cell markers in gliomas? Int J Clin Exp Pathol 6:334–348
    • (2013) Int J Clin Exp Pathol , vol.6 , pp. 334-348
    • Dahlrot, R.H.1    Hermansen, S.K.2    Hansen, S.3    Kristensen, B.W.4
  • 48
    • 34249332411 scopus 로고    scopus 로고
    • CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles
    • COI: 1:CAS:528:DC%2BD2sXltVyku74%3D, PID: 17483311
    • Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, Aigner L, Brawanski A, Bogdahn U, Beier CP (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67:4010–4015. doi:10.1158/0008-5472.CAN-06-4180
    • (2007) Cancer Res , vol.67 , pp. 4010-4015
    • Beier, D.1    Hau, P.2    Proescholdt, M.3    Lohmeier, A.4    Wischhusen, J.5    Oefner, P.J.6    Aigner, L.7    Brawanski, A.8    Bogdahn, U.9    Beier, C.P.10
  • 50
    • 0242329784 scopus 로고    scopus 로고
    • Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
    • COI: 1:CAS:528:DC%2BD3sXns1Cmu7k%3D, PID: 14520441
    • Yamanaka R, Abe T, Yajima N, Tsuchiya N, Homma J, Kobayashi T, Narita M, Takahashi M, Tanaka R (2003) Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial. Br J Cancer 89:1172–1179. doi:10.1038/sj.bjc.6601268
    • (2003) Br J Cancer , vol.89 , pp. 1172-1179
    • Yamanaka, R.1    Abe, T.2    Yajima, N.3    Tsuchiya, N.4    Homma, J.5    Kobayashi, T.6    Narita, M.7    Takahashi, M.8    Tanaka, R.9
  • 51
    • 20344372430 scopus 로고    scopus 로고
    • Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial
    • COI: 1:CAS:528:DC%2BD2MXks1Gks7c%3D, PID: 15930352
    • Yamanaka R, Homma J, Yajima N, Tsuchiya N, Sano M, Kobayashi T, Yoshida S, Abe T, Narita M, Takahashi M, Tanaka R (2005) Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial. Clin Cancer Res 11:4160–4167. doi:10.1158/1078-0432.CCR-05-0120
    • (2005) Clin Cancer Res , vol.11 , pp. 4160-4167
    • Yamanaka, R.1    Homma, J.2    Yajima, N.3    Tsuchiya, N.4    Sano, M.5    Kobayashi, T.6    Yoshida, S.7    Abe, T.8    Narita, M.9    Takahashi, M.10    Tanaka, R.11
  • 52
    • 3142692559 scopus 로고    scopus 로고
    • Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
    • COI: 1:CAS:528:DC%2BD2cXls1Omt7o%3D, PID: 15256471
    • Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ (2004) Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res 64:4973–4979. doi:10.1158/0008-5472.CAN-03-3505
    • (2004) Cancer Res , vol.64 , pp. 4973-4979
    • Yu, J.S.1    Liu, G.2    Ying, H.3    Yong, W.H.4    Black, K.L.5    Wheeler, C.J.6
  • 53
    • 69249149701 scopus 로고    scopus 로고
    • Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens
    • COI: 1:CAS:528:DC%2BD1MXht1Wqu7fO, PID: 19536809
    • Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J, Konda B, Black KL, Yu JS (2009) Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells 27:1734–1740. doi:10.1002/stem.102
    • (2009) Stem Cells , vol.27 , pp. 1734-1740
    • Xu, Q.1    Liu, G.2    Yuan, X.3    Xu, M.4    Wang, H.5    Ji, J.6    Konda, B.7    Black, K.L.8    Yu, J.S.9
  • 55
    • 84937528536 scopus 로고    scopus 로고
    • (2013) ImmunoCellular Therapeutics Phase II Study Demonstrates That Glioblastoma Patients Live Longer Without Disease Progression When Treated With ICT-107
    • (2013) ImmunoCellular Therapeutics Phase II Study Demonstrates That Glioblastoma Patients Live Longer Without Disease Progression When Treated With ICT-107
  • 58
    • 84877116624 scopus 로고    scopus 로고
    • Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma
    • COI: 1:CAS:528:DC%2BC3sXptlyjsLs%3D, PID: 23656794
    • Shen CJ, Yang YX, Han EQ, Cao N, Wang YF, Wang Y, Zhao YY, Zhao LM, Cui J, Gupta P, Wong AJ, Han SY (2013) Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma. J Hematol Oncol 6:33. doi:10.1186/1756-8722-6-33
    • (2013) J Hematol Oncol , vol.6 , pp. 33
    • Shen, C.J.1    Yang, Y.X.2    Han, E.Q.3    Cao, N.4    Wang, Y.F.5    Wang, Y.6    Zhao, Y.Y.7    Zhao, L.M.8    Cui, J.9    Gupta, P.10    Wong, A.J.11    Han, S.Y.12
  • 59
    • 38749092525 scopus 로고    scopus 로고
    • Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients
    • PID: 18097589
    • Wang LF, Fokas E, Bieker M, Rose F, Rexin P, Zhu Y, Pagenstecher A, Engenhart-Cabillic R, An HX (2008) Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. Oncol Rep 19:151–156
    • (2008) Oncol Rep , vol.19 , pp. 151-156
    • Wang, L.F.1    Fokas, E.2    Bieker, M.3    Rose, F.4    Rexin, P.5    Zhu, Y.6    Pagenstecher, A.7    Engenhart-Cabillic, R.8    An, H.X.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.